Misplaced Pages

Bedoradrine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Ultra-selective long-acting β2-adrenergic receptor agonist that was never marketed Pharmaceutical compound
Bedoradrine
Clinical data
Other namesKUR-1246; MN-221
Identifiers
IUPAC name
  • 2-ethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N,N-dimethylacetamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H32N2O5
Molar mass428.529 g·mol
3D model (JSmol)
SMILES
  • CN(C)C(=O)COC1=CC2=C(CC(C2)NC(C3=CC(=C(C=C3)O)CCO)O)C=C1
InChI
  • InChI=1S/C24H32N2O5/c1-26(2)24(30)15-31-21-7-4-16-3-6-20(12-19(16)13-21)25-14-23(29)17-5-8-22(28)18(11-17)9-10-27/h4-5,7-8,11,13,20,23,25,27-29H,3,6,9-10,12,14-15H2,1-2H3/t20-,23-/m0/s1
  • Key:OANCEOSLKSTLTA-REWPJTCUSA-N

Bedoradrine (INNTooltip International Nonproprietary Name; developmental code names KUR-1246, MN-221) is a sympathomimetic and bronchodilator medication that was developed for the treatment of preterm labor, asthma, and chronic obstructive pulmonary disease (COPD) but was never marketed. It acts as an ultra-selective long-acting β2-adrenergic receptor agonist. The drug was intended for intravenous administration.

See also

References

  1. ^ Antoniu S (August 2014). "Bedoradrine for treating asthma and chronic obstructive pulmonary disease". Expert Opin Investig Drugs. 23 (8): 1149–1156. doi:10.1517/13543784.2014.928284. PMID 24938936.
  2. ^ Cazzola M, Calzetta L, Matera MG (May 2011). "β(2) -adrenoceptor agonists: current and future direction". Br J Pharmacol. 163 (1): 4–17. doi:10.1111/j.1476-5381.2011.01216.x. PMC 3085864. PMID 21232045.
  3. "Bedoradrine: Uses, Interactions, Mechanism of Action". DrugBank Online. 18 November 2007. Retrieved 1 September 2024.
Tocolytics/labor repressants (G02CA)
β2 adrenoreceptor agonists
Oxytocin antagonists
NSAIDs
Calcium channel blockers
Myosin inhibitors
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Phenethylamines
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: